- Home
- CYCN vs MNDR Comparison
CYCN vs MNDR Comparison
Compare CYCN & MNDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- MNDR
- Stock Information
- Founded
- CYCN 2018
- MNDR 2016
- Country
- CYCN United States
- MNDR Singapore
- Employees
- CYCN N/A
- MNDR N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- MNDR
- Sector
- CYCN Health Care
- MNDR
- Exchange
- CYCN Nasdaq
- MNDR Nasdaq
- Market Cap
- CYCN 8.5M
- MNDR 10.1M
- IPO Year
- CYCN N/A
- MNDR 2024
- Fundamental
- Price
- CYCN $3.32
- MNDR $0.31
- Analyst Decision
- CYCN
- MNDR
- Analyst Count
- CYCN 0
- MNDR 0
- Target Price
- CYCN N/A
- MNDR N/A
- AVG Volume (30 Days)
- CYCN 9.1M
- MNDR 457.4K
- Earning Date
- CYCN 11-14-2024
- MNDR 02-16-2025
- Dividend Yield
- CYCN N/A
- MNDR N/A
- EPS Growth
- CYCN N/A
- MNDR N/A
- EPS
- CYCN N/A
- MNDR N/A
- Revenue
- CYCN $194,000.00
- MNDR $13,968,535.00
- Revenue This Year
- CYCN N/A
- MNDR $188,831.77
- Revenue Next Year
- CYCN N/A
- MNDR $76.44
- P/E Ratio
- CYCN N/A
- MNDR N/A
- Revenue Growth
- CYCN N/A
- MNDR 77.38
- 52 Week Low
- CYCN $1.27
- MNDR $0.23
- 52 Week High
- CYCN $9.47
- MNDR $29.50
- Technical
- Relative Strength Index (RSI)
- CYCN 52.12
- MNDR N/A
- Support Level
- CYCN $2.80
- MNDR N/A
- Resistance Level
- CYCN $3.43
- MNDR N/A
- Average True Range (ATR)
- CYCN 0.71
- MNDR 0.00
- MACD
- CYCN -0.07
- MNDR 0.00
- Stochastic Oscillator
- CYCN 19.26
- MNDR 0.00
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About MNDR Mobile-health Network Solutions Class A Ordinary Shares
Mobile-health Network Solutions is a company engaged in providing telehealth solutions in terms of various matrices, such as the number of patient consultations per day and the ranking of its mobile application. It provides services on its MaNaDr platform, which is accessible via mobile application and website. The MaNaDr platform is a platform designed and created by doctors, for doctors and users, equipped with services like consultations with doctors, e-commerce pharma store, and others. The company's operating segments are Telemedicine and other services which is also its key revenue generating segment, and Sale of medicine and medical devices. Geographically, it derives revenue from Singapore.